Invesco’s Nektar Therapeutics NKTR Stock Holding History

Invesco’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.8M	Buy	567,458 +99,299	+21%	+$5.65M	﹤0.01%	1147
2025 Q4	$19.8M	Buy	468,159 +241,262	+106%	+$13.5M	﹤0.01%	1472
2025 Q3	$12.9M	Buy	226,897 +194,865	+608%	+$6.45M	﹤0.01%	1675
2025 Q2	$828K	Sell	32,032 -9,516	-23%	-$107K	﹤0.01%	2922
2025 Q1	$424K	Sell	41,548 -2,154	-5%	-$28.1K	﹤0.01%	3218
2024 Q4	$610K	Buy	43,702 +581	+1%	+$10.2K	﹤0.01%	3156
2024 Q3	$841K	Buy	43,121 +173	+0.4%	+$3.3K	﹤0.01%	2988
2024 Q2	$799K	Buy	42,948 +7,858	+22%	+$166K	﹤0.01%	3052
2024 Q1	$492K	Buy	35,090 +14,830	+73%	+$155K	﹤0.01%	3348
2023 Q4	$172K	Sell	20,260 -3,696	-15%	-$28K	﹤0.01%	3595
2023 Q3	$214K	Sell	23,956 -345,073	-94%	-$3.32M	﹤0.01%	3571
2023 Q2	$3.18M	Sell	369,029 -2,129,810	-85%	-$22.7M	﹤0.01%	2458
2023 Q1	$26.3M	Buy	2,498,839 +10,341	+0.4%	+$313K	0.01%	1212
2022 Q4	$84.4M	Buy	2,488,498 +4,255	+0.2%	+$206K	0.02%	758
2022 Q3	$119M	Buy	2,484,243 +2,219	+0.1%	+$132K	0.04%	604
2022 Q2	$141M	Sell	2,482,024 -12	-0%	-$757	0.04%	553
2022 Q1	$201M	Buy	2,482,036 +22,603	+0.9%	+$3.35M	0.05%	496
2021 Q4	$498M	Buy	2,459,433 +81,354	+3%	+$17.6M	0.12%	198
2021 Q3	$641M	Buy	2,378,079 +854	+0%	+$205K	0.16%	130
2021 Q2	$612M	Buy	2,377,225 +13,932	+0.6%	+$3.86M	0.15%	149
2021 Q1	$709M	Sell	2,363,293 -504	-0%	-$157K	0.19%	114
2020 Q4	$603M	Sell	2,363,797 -15,620	-0.7%	-$4.04M	0.18%	124
2020 Q3	$592M	Buy	2,379,417 +167,374	+8%	+$52.6M	0.2%	101
2020 Q2	$768M	Sell	2,212,043 -49,384	-2%	-$15.4M	0.27%	68
2020 Q1	$605M	Buy	2,261,427 +152,818	+7%	+$47.3M	0.25%	86
2019 Q4	$683M	Sell	2,108,609 -200,950	-9%	-$58.3M	0.21%	102
2019 Q3	$631M	Buy	2,309,559 +753,358	+48%	+$276M	0.17%	131
2019 Q2	$831M	Buy	1,556,201 +1,421,782	+1,058%	+$713M	0.21%	90
2019 Q1	$67.7M	Buy	134,419 +13,929	+12%	+$8.25M	0.02%	694
2018 Q4	$59.4M	Buy	120,490 +8,658	+8%	+$5.23M	0.02%	680
2018 Q3	$102M	Sell	111,832 -29,196	-21%	-$24.9M	0.03%	554
2018 Q2	$103M	Buy	141,028 +39,818	+39%	+$45.9M	0.03%	539
2018 Q1	$161M	Sell	101,210 -29,353	-22%	-$37.8M	0.06%	328
2017 Q4	$117M	Sell	130,563 -110,287	-46%	-$65.2M	0.04%	442
2017 Q3	$86.7M	Sell	240,850 -86	-0%	-$26.9K	0.03%	562
2017 Q2	$70.7M	Sell	240,936 -43,094	-15%	-$12.5M	0.02%	614
2017 Q1	$100M	Sell	284,030 -11,891	-4%	-$2.67M	0.03%	507
2016 Q4	$54.5M	Buy	295,921 +6,080	+2%	+$1.24M	0.02%	729
2016 Q3	$74.7M	Buy	289,841 +1,648	+0.6%	+$424K	0.03%	608
2016 Q2	$61.5M	Sell	288,193 -6,634	-2%	-$1.48M	0.02%	662
2016 Q1	$60.8M	Buy	294,827 +3,073	+1%	+$590K	0.02%	652
2015 Q4	$73.7M	Buy	291,754 +11,922	+4%	+$2.45M	0.03%	615
2015 Q3	$46M	Buy	279,832 +11,003	+4%	+$1.95M	0.02%	778
2015 Q2	$50.4M	Buy	268,829 +25,980	+11%	+$4.47M	0.02%	798
2015 Q1	$40.1M	Sell	242,849 -32,795	-12%	-$6.74M	0.02%	901
2014 Q4	$64.1M	Buy	275,644 +153,127	+125%	+$32.7M	0.02%	682
2014 Q3	$22.2M	Buy	122,517 +70,205	+134%	+$13.4M	0.01%	1141
2014 Q2	$10.1M	Sell	52,312 -66,021	-56%	-$11.7M	﹤0.01%	1549
2014 Q1	$21.5M	Buy	118,333 +47,820	+68%	+$9.46M	0.01%	1160
2013 Q4	$12M	Buy	70,513 +25,307	+56%	+$4.08M	﹤0.01%	1436
2013 Q3	$7.08M	Buy	45,206 +44,333	+5,078%	+$8.2M	﹤0.01%	1685
2013 Q2	$151K	Buy	+873	New	+$134K	﹤0.01%	3771

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return